Nyxoah Présente une Mise à Jour Concernant la Lettre d'Approuvabilité de la FDA pour le Système Genio

Nyxoah Présente une Mise à Jour Concernant la Lettre d'Approuvabilité de la FDA pour le Système Genio
Prévoit de satisfaire aux exigences finales de la FDA pour obtenir l'approbation PMA complète au cours du deuxième trimestre

Mont–Saint–Guibert, Belgique – 8 avril 2025, 07h00 CET / 01h00 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie médicale développant des alternatives thérapeutiques innovantes pour l'apnée obstructive du sommeil (AOS) par la neuromodulation, a annoncé aujourd'hui une mise à jour sur le processus d'approbation du système Genio par la FDA.

Le 26 mars 2025, la Société a annoncé que la Food and Drug Administration (FDA) des États–Unis avait émis une lettre d'approuvabilité (“Approvable Letter) concernant la demande d'approbation préalable à la mise sur le marché (PMA) de la Société pour le système Genio®.

La lettre d'approuvabilité (“Approvable Letter) signifie que la demande de Nyxoah pour la commercialisation du dispositif aux États–Unis répond en grande partie aux exigences de la loi fédérale sur les aliments, les médicaments et les cosmétiques (Federal Food, Drug and Cosmetic Act) et aux règlements d'application de la PMA de la FDA codifiés à la section 814 du 21 C.F.R., et que la FDA approuvera la demande sous réserve de l'achèvement satisfaisant d'un examen des installations de fabrication, des méthodes et des contrôles. La FDA a accepté toutes les autres données fournies avec la demande de PMA, y compris et surtout l'étude clinique qui démontre la sécurité et l'efficacité du système Genio®.

Nyxoah s'occupe activement d'un point restant avant que l'approbation de la FDA ne soit éventuellement accordée, à savoir la validation d'un processus utilisé avec un composant du système Genio sur son site de fabrication aux États–Unis. La Société est convaincue qu'elle sera en mesure de mener à bien cette validation à court terme. Ainsi, Nyxoah prévoit que sa demande pourrait être approuvée au cours du deuxième trimestre et prévoit de fournir une mise à jour sur le processus d'examen lors de sa conférence téléphonique sur les résultats du premier trimestre 2025, qui aura lieu en mai.

“Nous sommes heureux d'annoncer que la lettre d'approuvabilité de la FDA confirme que nous sommes très proches de l'approbation PMA,” a commenté Olivier Taelman, Chief Executive Officer de Nyxoah. “Nous pensons que la dernière étape restante est l'achèvement de la validation d’un processus sur notre site de production aux États–Unis – une mesure prise en réponse à la dernière série de questions spécifiques de validation envoyées par la FDA – que nous sommes convaincus de pouvoir traiter rapidement et avec succès. Nous sommes impatients de lancer Genio aux États–Unis dès que nous aurons reçu l'approbation de la FDA.”

A propos de Nyxoah
Nyxoah opère dans le secteur des technologies médicales. Elle se concentre sur le développement et la commercialisation de solutions innovantes destinées à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS). La principale solution de Nyxoah est le système Genio®, une thérapie de neurostimulation du nerf hypoglosse sans sonde et sans batterie qui a reçu le marquage CE, centrée sur le patient et destinée à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS), le trouble respiratoire du sommeil le plus courant au monde. Ce dernier est associé à un risque accru de mortalité et des comorbidités, dont les maladies cardiovasculaires. La visions de Nyxoah est que les patients souffrant de SAOS doivent pouvoir profiter de nuits réparatrices et vivre pleinement leur vie.

À la suite de la finalisation probante de l’étude BLAST OSA, le système Genio® a reçu le marquage européen CE en 2019. Nyxoah a réalisé avec succès deux IPO : l’une sur Euronext Bruxelles en septembre 2020 et l’autre sur le NASDAQ en juillet 2021. Grâce aux résultats positifs de l'étude BETTER SLEEP, Nyxoah a reçu le marquage CE pour l’extension de ses indications thérapeutiques aux patients souffrant de collapsus concentrique complet (CCC), pour lesquels les thérapies concurrentes sont actuellement contre–indiquées. En outre, la Société a annoncé les résultats positifs de l'étude pivot DREAM IDE.

Pour plus d’informations, visitez www.nyxoah.com

Attention – Marquage CE depuis 2019. Dispositif de recherche aux États–Unis. Limité à un usage expérimental aux États–Unis par la loi fédérale américaine.

Déclarations Prospectives

Certaines déclarations, croyances et opinions contenues dans le présent communiqué de presse sont de nature prospective et reflètent les attentes actuelles de la Société ou, le cas échéant, des administrateurs ou de la direction de la Société concernant le système Genio®, les études cliniques prévues et en cours sur le système Genio®, les avantages potentiels du système Genio®, les objectifs de Nyxoah concernant le développement, la voie réglementaire et l'utilisation potentielle du système Genio®, l'obtention de l'approbation de la FDA, l'achèvement satisfaisant de l'examen des installations de fabrication, des méthodes et des contrôles, et le calendrier prévu pour ce qui précède, l'entrée sur le marché américain, ainsi que les résultats d'exploitation, la situation financière, les liquidités, les performances, les perspectives, la croissance et les stratégies de la Société. De par leur nature, les déclarations prévisionnelles impliquent un certain nombre de risques, d'incertitudes, d'hypothèses et d'autres facteurs qui pourraient faire en sorte que les résultats ou les événements réels diffèrent matériellement de ceux exprimés ou sous–entendus dans les déclarations prévisionnelles. Ces risques, incertitudes, hypothèses et facteurs pourraient avoir une incidence négative sur les résultats et les effets financiers des plans et des événements décrits dans le présent document. En outre, ces risques et incertitudes comprennent, sans s'y limiter, les risques et incertitudes énoncés dans la section « Facteurs de risque » du rapport annuel de la Société sur le formulaire 20–F pour l'exercice clos le 31 décembre 2024, déposé auprès de la Securities and Exchange Commission (« SEC ») le 20 mars 2025, et des rapports ultérieurs que la Société dépose auprès de la SEC. Une multitude de facteurs, y compris, mais sans s'y limiter, les changements dans la demande, la concurrence et la technologie, peuvent faire en sorte que les événements, les performances ou les résultats réels diffèrent de manière significative de tout développement anticipé. Les déclarations prospectives contenues dans le présent communiqué de presse concernant des tendances ou des activités passées ne constituent pas des garanties de performances futures et ne doivent pas être considérées comme une déclaration selon laquelle ces tendances ou activités se poursuivront à l'avenir. En outre, même si les résultats ou développements réels sont conformes aux déclarations prospectives contenues dans le présent communiqué de presse, ces résultats ou développements peuvent ne pas être représentatifs des résultats ou développements des périodes futures. Aucune déclaration ou garantie n'est donnée quant à l'exactitude ou à la justesse de ces déclarations prospectives. En conséquence, la Société décline expressément toute obligation ou tout engagement de publier des mises à jour ou des révisions des déclarations prospectives contenues dans le présent communiqué de presse à la suite d'un changement des attentes ou d'un changement des événements, conditions, hypothèses ou circonstances sur lesquels ces déclarations prospectives sont basées, sauf si la loi ou la réglementation l'exige expressément. Ni la Société, ni ses conseillers ou représentants, ni aucune de ses filiales, ni les dirigeants ou employés de ces personnes ne garantissent que les hypothèses sous–jacentes à ces déclarations prospectives sont exemptes d'erreurs et n'acceptent aucune responsabilité quant à l'exactitude future des déclarations prospectives contenues dans ce communiqué de presse ou quant à la survenance effective des développements prévus. Vous ne devriez pas accorder une confiance excessive aux déclarations prospectives, qui ne sont valables qu'à la date du présent communiqué de presse.

Contacts :

Nyxoah
John Landry, CFO
IR@nyxoah.com

Medias
Aux États–Unis
FINN Partners – Alyssa Paldo
alyssa.paldo@finnpartners.com

International / Allemagne
MC Services – Anne Hennecke
nyxoah@mc–services.eu

Belgique / France
Backstage Communication – Gunther De Backer
gunther@backstagecom.be

Pièce jointe


GLOBENEWSWIRE (Distribution ID 1001078888)

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Nyxoah Provides Update on FDA Approvable Letter for Genio System
Expects to meet final FDA requirements for full PMA approval in the second quarter

Mont–Saint–Guibert, Belgium – April 8, 2025, 07:00am CET / 1:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), which develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced an update on the FDA approval process for the Genio system.

On March 26, 2025, the Company announced that the U.S. Food and Drug Administration (FDA) issued an Approvable Letter regarding the Company's Pre–Market Approval (PMA) application for the Genio® system.

The Approvable Letter means that Nyxoah’s application for marketing the device in the United States substantially meets the requirements of the Federal Food, Drug and Cosmetic Act and the FDA’s PMA implementing regulations codified at 21 C.F.R. Part 814, and the FDA will approve the application subject to satisfactory completion of a manufacturing facilities, methods and controls review. FDA has accepted all other data provided with the PMA submission, including most importantly the clinical study that demonstrates the safety and effectiveness of the Genio® system.

Nyxoah is actively addressing one remaining item before FDA approval may be granted which is the validation of one process used with a component of the Genio system at its U.S. manufacturing site. The Company is confident that it will be able to successfully complete this validation in the near term. As such, Nyxoah anticipates that its application could potentially be approved in the second quarter and intends to provide an update on the review process on its first quarter 2025 earnings call to be held in May.

“We are pleased to share that the Approvable Letter from FDA confirms that we are very close to PMA approval,” commented Olivier Taelman, Nyxoah’s Chief Executive Officer. “We believe the final remaining step is completing a process validation at our U.S. manufacturing site – action taken in response to the last set of specific validation questions sent by the FDA – which we are confident we can address swiftly and successfully. We look forward to launching Genio in the U.S. upon receipt of FDA approval.”

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient–centered, leadless and battery–free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States

FORWARD–LOOKING STATEMENTS

Certain statements, beliefs and opinions in this press release are forward–looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; receipt of FDA approval; satisfactory completion of a manufacturing facilities, methods and controls review, and the anticipated timing of the foregoing; entrance to the U.S. market; and the Company's results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward–looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward–looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20–F for the year ended December 31, 2024, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2025, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward–looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward–looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward–looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward–looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward–looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward–looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward–looking statements, which speak only as of the date of this press release.

Contacts:

Nyxoah
John Landry, CFO
IR@nyxoah.com

For Media
In United States
FINN Partners – Alyssa Paldo
alyssa.paldo@finnpartners.com

In International/Germany
MC Services – Anne Hennecke
nyxoah@mc–services.eu

In Belgium/France
Backstage Communication – Gunther De Backer
gunther@backstagecom.be

Attachment


GLOBENEWSWIRE (Distribution ID 1001078888)

The Current Plight of Haitians: Interview with a Mason in the Dominican Republic

Members of a Haitian family return from the Dominican Republic carrying the few possessions they have. Credit: IOM/Antoine Lemonnier

By Jan Lundius
SANTO DOMINGO, Dominican Republic, Apr 8 2025 – On March 18, the first plane with deportees from the US landed in Cap-Haïtien. Of the 46 passengers, 25 were convicted felons. Taking effect on April 24 the US Department of Homeland Security will revoke the temporary legal status of more than 210,000 Haitians. They had by the Biden administration been granted a safe haven, but all these Haitians are now expected to be deported back to a country immersed in a humanitarian crisis.

Escaping poverty and violence, Haitians have also crossed the border into neighboring Dominican Republic, where they are constantly running the risk of being captured and transported back across the border. An activity that has given rise to a multifaceted and difficult-to-investigate corruption, including politicians, lawyers and the police. In 2024, The Dominican Republic deported more than 270,000 Haitians. In the last three months of this year alone, over 90, 000 “foreigners with irregular status” have been deported under a new operation aiming to remove 10,000 undocumented Haitians per week. This from a country where more than 75 percent of the estimated 800,000 Haitians are working full-time, particularly in agriculture and construction.

In the past month alone, violence in Haiti’s capital, Port-au-Prince displaced over 60,000 people. Only since the beginning of March, attacks by armed gangs have displaced more than 24,000 people. Desperate people are seeking refuge in 48 displacement sites, others have turned to host families. Despite ongoing efforts, the scale of need far exceeds available resources, this while the Trump administration has ended the USAID’s support to Haiti.

Efforts to curb gang violence have so far been inadequate. A UN supported contingent of around 800 Kenyan police, working alongside Haiti’s National Police, is leading a mission against the gangs, who are supported by drug- and arms traffickers. So far, one Kenyan officer has been killed and two others have been seriously injured.

Violence has escalated since October last year, when gangsters attacked the town of Pont-Sondé, killing 115 people. In November, gang attacks forced more than 20,000 people to leave their homes in the Capital. Between December 6 and 11, at least 200 innocent people were killed by gangsters in Wharf Jérémie, one of the worst slums in Port-au-Prince. In the same month, a community self-defence group lynched 10 gang members in l’Artibonite, the response was not long in coming and approximately 100 men, women and children were wantonly murdered. On December 17, a gang attacked the Hôpital Bernard Mevs in Port-au-Prince, setting it on fire and on Christmas Eve, gangs attacked the Hôpital général, the Capital’s largest hospital, killing several patients, at least two journalists and a police officer. Since then, the killings and general abuse have not ceased. People are getting increasingly desperate. On March 20, when protesters demanding protection tried to reach the Prime Minister’s office, the police dispersed the crowd by firing tear gas. At least 85 percent of Port-au-Prince is currently controlled by armed, criminal gangs.

No airlines fly to Port-au-Prince anymore. US aviation authorities have indefinitely banned all flights . If you want to get out from the country the only open airport is in Cap-Haïtien and you have to fly by helicopter. The cost is USD 2,500 and you are only allowed to bring 10 kilos of luggage. By early 2025, the number of people forced to leave their homes as a result of gang violence had reached over a million.

All this on top of earthquakes, hurricanes, centuries of political oppression and catastrophic environmental degradation. Born as the world’s first republic ruled by former slaves, Haiti has for more than two centuries suffered from the racist contempt of the outside world and an overpopulation originally caused by the 800,000 slaves imported by the French to their colony of Saint-Domingue (which later became Haiti). A country which tropical soils could not even then feed them all. On top of the misery, Haiti was until 1947 forced to pay reparations for taking possession of the “property” that their French oppressors had usurped.

To place a human face on the current situation we interviewed a skilled Haitian worker living in the Dominican Republic. For obvious reasons he wanted to remain unidentified.

How old are you and for how many years have you been living in the Dominican Republic?

I am 43 years old and have been working here for 28 years.

How did you first come here and what did you work with then?

I bought a false passport and a visa, something that made my entry legal and began to work collecting coffee for 50 cents a day, later on I could earn the equivalent of one US dollar a day, by weeding fields and collecting tomatoes.

Why did you leave Haiti and do you still have a family there?

I come from a village outside of Thomassique, not far from the Dominican border. We are eight siblings, my five brothers still live there, as well as my two sisters. The soil does not yield as much as before, being constantly degraded by draught. My father opposed he Duvalier regime and the Tonton Macoutes [secret police/militia] wanted to kill him. He was in hiding for six years until he died when I was eleven. We were starving. When I was fifteen, I left for the Dominican Republic. Every other year I try to visit Haiti. I have two sons living there, 12 and 13 years old. They live with a brother of mine and go to school there. I also have a 14 years old girl , who for five years has been living with us here in the Dominican Republic. She lacks papers and I had to take her out of the public school. So far, I cannot afford a private one.

You are now working with masonry. What is your education?

I went to school up until the sixth grade. I had to quit to help my mother and siblings. In the Dominican Republic my earnings were hardly enough to sustain myself. However, a friend helped me to find a job where I learned to do masonry and produce tiles. I am now able to do any kind of skilled masonry.

How much do you earn?

I am no longer with the masonry workshop, earning better by collaborating with an engineer involved with the construction of private villas. It is not a steady work. I am paid per hour and if I work from sunrise to sunset, I can generally earn the equivalent of 15 US dollars. Covering a middle-sized kitchen with tiles would earn me around 30 dollars. However, I seldom find work for more than fifteen days a month. I have to send money for my children in Haiti and support my wife and daughter her in the Dominican Republic.

Is your wife working as well?

No, she cannot even leave the apartment.

Why not?

She does not have any papers and I cannot afford getting any, neither for her, nor for our daughter. They risk to be caught in the street and deported to Haiti. Paperless Haitians are rounded up and brought to a compound, when enough are assembled they are locked up in special, barred busses and brought to the border, where they are let off. Some are not even born in Haiti; they have to find their way as best as they can. The trip to the frontier means several hours without food or water, and no possibility to visit the toilet. Mothers caught in this manner have to leave their children behind, to care for themselves until someone brings them to the authorities. If you are caught, the police generally ask for the equivalent of 5 dollars to let you go, not all are carrying so much money.

Would you prefer to live in Haiti?

Of course, there you feel free. You are among friends and equals. Dominicans assume they are better than Haitians. They look down upon us and depict us as criminals. To consider all Haitians as enemies to Dominican wellbeing has for centuries been part of Dominican politics. I understand them … no one wants strangers living in their house. I have no problem with the Dominicans I work together with, they respect my skills. However, everywhere else I feel questioned and despised.

Do you have a work permit?

I have to renew it every year and to do so I have to pay a lawyer working with the Dirección General de Migración. Before you could do it on your own. The lawyer arranges all the papers for you, and computerizes them. It is big business; the papers do not exist in reality. It costs me 25 dollars every year. Without work permit you live in fear all the time.

What do you want most of all?

To find work in any country except here. In Haiti, I cannot support myself, but with my skills it is possible anywhere else. If I could afford it, I would travel to Mexico and cross the border into the US. I might also find work in Latin America.

After our interview, which was carried out in another town, the mason took the bus back to Santo Domingo. The driver noticed his work tools and assumed he carried money. When the other passengers had left the bus in Santo Domingo, the mason was detained by the driver and his assistant, who demanded more money. If the mason did not pay, they threatened to denounce him to the authorities. When he said he had a work permit the driver menaced him with a machete. However, a bystander noticed what was happening and convinced the assailants to let him go.

IPS UN Bureau

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

Growing Legacy: Raising Ambition in Agriculture Scientific Research as CGIAR Unveil New Portfolio

As the Global South reaches concerning food and nutrition security levels, experts say science will turn around the trajectory of extreme poverty and hunger. Credit: Joyce Chimbi/IPS

As the Global South reaches concerning food and nutrition security levels, experts say science will turn around the trajectory of extreme poverty and hunger. Credit: Joyce Chimbi/IPS

By Joyce Chimbi
NAIROBI, Apr 8 2025 – Global food and nutrition insecurity levels are hurtling towards a catastrophe. To counter these problems, leading world experts say science is the ‘silver bullet.’ That science will build climate-resilient agri-food systems, improve livelihoods across the value chain, and ensure more affordable, nutritious food while safeguarding the environment.

“We want a positive impact on the global food security. Science is about bringing us insights into issues so that we can then have an impact. Food security cannot happen without science, without research, without data, without analysis, without information, without intelligence, and without thought,” said CGIAR Executive Managing Director Ismahane Elouafi.

“CGIAR scientists will present to you our new research portfolio for 2025-2030, which we believe will really tackle the challenges that we are talking about in the Science Week. We have an incredible team of scientists who really envisioned what the organization can achieve in the coming years. We grow our robust research in high-risk systems and context-specific settings to achieve effective solutions.”

“The most important aspect is the ongoing work on the ground and in the industries, in the field and laboratories, and it is why we need our scientists and partners to come together. Our science research program can provide solutions but those solutions have to be made by people. For this reason, we need to meet in person and virtually and engage so that we live up to set goals.”

CGIAR Executive Managing Director Ismahane Elouafi on the first day of Science Week. Credit: CGIAR

CGIAR Executive Managing Director Ismahane Elouafi on the first day of Science Week. Credit: CGIAR

During the second day’s plenary session, there was a special focus on the CGIAR’s new research portfolio and on exploring strategies for effectively scaling innovations to ensure they reach farmers and consumers worldwide. With a focus on addressing the major challenges to food, land, and water systems sustainability, participants were given insights into how CGIAR’s work aligns with the Sustainable Development Goals and contributes to global efforts for agricultural transformation.

Dr. Sandra Milach, CGIAR’s Chief Scientist, told participants where the organization’s scientific revolution all started. Nearly 50 years ago, CGIAR turned to science for solutions by building centers to address segregation in countries still dealing with the effects of centuries of colonization. The organization built farms and lifted millions from hunger in Africa, Asia, and many parts of Latin America.

“However, the world today is different, very different. Yes, we still have global food and water emergencies that we need to address, but we are also facing climate change, biodiversity loss, and new conflicts. Very difficult indeed. Once again, we need and must build capabilities to address these new problems. We have done it before. I’m very confident we will do it again. In 2021, we refocused our strategy to rebuild and do so around five important impact areas, including nutrition, livelihoods, gender, climate, and biodiversity,” Milach said.

Over the years, CGIAR’s mandate has been shaped by an evolving global crisis and they have developed their capabilities to match contemporary problems. She talked about CGIAR’s cutting-edge research and initiatives designed to tackle these pressing issues and discuss the pathways for translating scientific discoveries into tangible benefits for communities on the ground.

By highlighting the intersections between CGIAR’s research and broader international development agenda, she said the organization aims to underscore the importance of collaborative efforts in driving progress towards a sustainable and food-secure future. Emphasizing that the new research portfolio 2025-2030 is big and ambitious, as it for instance, seeks to reduce the number of people affected by extreme hunger by 26 percent and that is 1.82 million people, by 2030. Saying that this is nearly the size of her native country, Brazil.

“Our scientists know how to produce more crops and even more new crops. Our green fields are large and well-established, but we will need to look critically at all the staple crops, bio-fortified crops, and forgotten crops to understand what needs to be done tomorrow. Our scientists also have the knowledge and innovations to empower livestock keepers and fishermen and make sustainable animal and animal food production a core offering. But we will make sure not to design our research programs solely to produce more food. Equally important, better diets and nutrition are central to our work,” Milach.

“By 2030, it is our mission to lift 31 million people from extreme poverty and it will be the foundation of what we do. We hope also to create 92 million jobs, a number equal to the workforce of any nation, just to give you a perspective. Indeed, by improving farms and helping farmers, we will also benefit the environment so that jobs are created around the environment. And we will do it while increasing the average income by 87 percent. This is our pledge.”

Another priority goal will be to prevent 500 million tons of emissions by 2030. Milach said the innovations are just as important as the knowledge and that CGIAR will also build on indigenous and traditional food practices and that knowledge created through these systems will travel across borders. The issue of gender and social inclusion will feature prominently in the new portfolio and specifically towards increasing women and youth employment in the agri-food system and sector.

“Importantly, technologies can be adapted and developed beyond the communities they were designed for. In a more fragile world that we live in today, we have a duty to the smallholder farmers. But not only that, to the communities that they serve. We will need our science to adapt to new food frontiers and security contexts. Especially food producers in urban areas, in islands, and in conflict zones that exist across the world,” she reiterated.

“Our reform was designed to tackle the biodiversity crisis. One million species are at risk of extinction. By 2030, we want to deliver an innovation that will protect 20 billion hectares of land for expansion. This represents 25 percent of the size of the Amazon forest.  But we cannot focus on one parcel of land, one waterway, one specific crop, or one biome. We need to use less land and we need to build a bigger land and this can be achieved through environmentally sound solutions.”

Panel discussions in plenary buttressed her remarks by emphasizing the critical role of science in promoting climate-smart agriculture and in proper diversification, soil health, better conservation and conservation practices, and in addressing water scarcity. Overall, CGIAR is designed to prioritize the organization’s impact within their global mission. While also setting the tone for the global science community so that science can serve people and communities.
IPS UN Bureau Report

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);